Novartis to test efficacy of old malaria drug against COVID-19

Swiss drugmaker Novartis AG said on Monday it will test the malaria drug hydroxychloroquine in a randomized trial to see if the much talked about medicine is actually effective against COVID-19, the illness caused by the novel coronavirus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news